Skip to main content

Tsourapas Panagiotis's Form 4 filing

Colgate Palmolive Co (CL) · filed Feb 13, 2026

Accession no.
0001225208-26-001844
Filed
Feb 13, 2026
Trade date
Feb 11-12, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.78M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tsourapas PanagiotisCIK 0001576945Officer (COO, Eur., APac, Afr Eur, Skin)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 11, 2026Common StockMOption exerciseAcquired+35,000$76.41+$2,674,35045,415Direct
Feb 11, 2026Common StockSSaleDisposed−35,000$94.61F3−$3,311,35010,415Direct
Feb 12, 2026Common StockMOption exerciseAcquired+15,000$76.41+$1,146,15025,415Direct
Feb 12, 2026Common StockSSaleDisposed−15,000$97.81F4−$1,467,15010,415Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 11, 2026Common StockMOption exerciseDisposed−35,000$0.00$034,938Direct
Feb 12, 2026Common StockMOption exerciseDisposed−15,000$0.00$019,938Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)